99% Purity Nootropics Supplement Powder Prl-8-53 HCl CAS 51352-87-5
Superioridad
Zhongshan Latterson Biotechnology Co., Limitado., es una empresa farmacéutica integral, que se especializó en tecnología biofarmacéutica sobre 7 años. La empresa está ubicada en la ciudad de Zhongshan, Provincia de Guangdong , porcelana.
Nuestra fábrica cubre un área de 33500 metros cuadrados, con un ambiente limpio y un diseño agradable. Hay varios talleres grandes o medianos y un centro de investigación y control de calidad con equipos avanzados.. En el presente, Nuestros principales productos son la serie de esteroides anabólicos., Serie de péptidos, Serie de anestésicos locales. Nuestros productos alcanzan el estándar avanzado del mercado nacional., muchos de los cuales alcanzan el estándar internacional, los certificados contienen: COMESTIBLE SEGÚN LA LEY JUDÍA , YO ASI 9001:2008 , GMP , SGS.
Product Details:
| nombre del producto |
PRL-8-53 HCL |
| As |
Prl-8-53 HCL |
| CASO |
51352-87-5 |
| MF |
C18H22ClNO2 |
| MW |
319.82578 |
| Pureza |
99.50% |
| Calificación |
As |
| Apariencia |
polvo cristalino blanco. |
| Estándar |
USP |
| Stock |
Mass Stock |
| Uso |
PRL-8-53 HCL improves brain circulation |
Descripción:
PRL-8-53 (chemical name Methyl 3-(2-(benzyl(methyl)aminado)ethyl)benzoate) is a synthetic nootropic compound discovered in 1972 and patented in 1975 by the late Dr. Nikolaus Hansl, a neuropharmacologist at Creighton University in Omaha, Nebraska. Preliminary animal tests indicated that the compound was both safe and significantly nootropic, boosting avoidance learning in rodents with no adverse effects. But the real interest in PRL-8-53 was sparked by a 1978 study on human volunteers, which showed that a single dose of the compound could improve word retention scores by more than 200%. The single study involving humans showed PRL-8-53 improved word recollection scores both 24 Estanozolol semielaborado de la serie líquida de esteroides 96 hours after initial memorization. Given the low amount of evidence available for this nootropic, we thought it relevant to reference a journal article in which the creator discusses the compound and numerous other human trials it was used in.
Solicitud:
PRL-8-53’s exact mechanisms of action are not well understood, but it is generally believed to regulate the brain’s production of and response to several crucial neurotransmitters. In his reports on human and animal studies Hansl indicated that PRL-8-53 potentiates dopamine, partially restricts production of serotonin, and enhances the brain’s response to acetylcholine.
Though Hansl’s research report on the 1978 human study suggests those actions, it does not clearly delineate the mechanism of action.The fact that older subjects saw the most nootropic benefit from taking the drug supports the concept that dopamine modulation plays a major role in PLR-8-53’s effects. Up-regulating the normal age-related lessening of dopamine production that is associated with cognitive decline could have a significant positive impact on both learning and memory.
COA:
| Artículo |
Inspection Standard |
Resultados |
| Apariencia |
Off white solid powder |
Ajustarse |
| Identificación |
Conform with NMR |
Cumple |
| Punto de fusion |
149-152° C |
150-151° C |
| Loss on Drying |
≤0.50% |
0.21% |
| Residuos en ignición |
≤1.0% |
0.32% |
| Pureza(HPLC) |
≥99% |
99.2% |
| Metales pesados |
NMT 20PPM |
Cumple |
| Conclusión:This product by inspection accords with the in-house standard |
Beneficios:
It is generally considered to be a memory and learning enhancer. In the lone study with rats, taking PRL-8-53 120 – 150 minutes before a cognitive test helped drastically. Memory was tested at 24 hours after dosing and 96 hours with positive results compared to a placebo. Within these tests, some of the test performance improvements were in the range of 80 – 100+%, which suggests significant potential. The study separated the analysis of memory and “working memory”, which showed less improvement, but still notable.
Dossage:
More evidence is needed to determine the ideal dosage for PRL-8-53. The effective dosage may vary, since the only human study on PRL-8-53 used a single dose of 5mg, while patent information on PRL-8-53 suggests a dosage range of 0.01-4mg/kg, with an ‘ideal’ range of 0.05-1.2mg/kg.
Nuestro servicio
1.100% La política de reenvío es nuestro negocio básico. Reenvío del 100% inmediatamente si su paquete permanece en Aduana por 4 días y no se actualiza.
2.Reembolso total por 15 días de insatisfacción con la calidad.
3.Podemos proporcionar muestras gratis..
4.Tenemos un embalaje especial ,Se puede pasar fácilmente por la aduana.Será más seguro..
5.Nuestra empresa tiene una cooperación a largo plazo con DHL.EMS.Fedex y así sucesivamente. Se puede enviar a su mano más rápidamente. La foto del paquete debe ofrecerse dentro de las 12 horas posteriores a la recepción de su pago de esteroides.
6.Si tienes la oportunidad de venir a China. Puedo mostrarte nuestro laboratorio.
7.Nuestra empresa tiene WU, MG, TT, y formas de pago de Bitcoin por adelantado. 95% por el costo de los péptidos al principio por pedido, el resto nos lo puede ofrecer en su próximo pedido;
| Otros productos de venta caliente (Polvo crudo) |
| TUDCA (Ácido tauroursodesoxicólico) |
| GBL (Y-butirolactona) |
| 1,4-Butanodiol |
| minoxidil |
| melatonina |
| tretinoína |
| Sunifiram |
| Pregabalina |
| fenacetina |
| Paracetamol |
| Levamisol HCL |
| Pirfenidona |
| Epinefrina HCL |
| pregnenolona |
| Bromhidrato de dextrometorfano monohidrato |
| argirelina |
| SNAP-8 1 mg/vial |
| Teofilina |
| Diclofenaco sódico |
| Sal sódica de tianeptina |
| Noopept |
| Mononucleótido de beta-nicotinamida |
| propionato de clobetasol |
| polietilenglicol(CLAVIJA) |
| ketoprofeno |
| 1,3-clorhidrato de dimetilbutilamina |
| polivinilpirrolidona |
| baricitinib |
| diprofilina |
Gerente de ventas